Thad Bourque, MD
Urology · Lafayette, LANPI 1912093709
Payments from drug & device makers
Across 304 payments — averaging $646.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$138K
- Janssen Research & Development, LLC$51K
- Teleflex LLC$1K
- Astellas Pharma US Inc$925
- AbbVie$835
- Johnson & Johnson$645
- plus $3K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 34 | $138,351 |
| Janssen Research & Development, LLC | 2 | $50,791 |
| Teleflex LLC | 13 | $1,466 |
| Astellas Pharma US Inc | 63 | $925 |
| AbbVie(2 entities) | 41 | $835 |
| Johnson & Johnson(2 entities) | 20 | $645 |
| Dendreon Pharmaceuticals LLC | 20 | $641 |
| Pfizer | 26 | $612 |
| Bioprotect Medical, Inc. | 8 | $312 |
| Merck | 10 | $237 |
| Bayer | 7 | $227 |
| Coloplast | 11 | $174 |
| Ferring Pharmaceuticals Inc. | 2 | $165 |
| Procept Biorobotics Corporation | 1 | $135 |
| Boston Scientific | 5 | $119 |
| Myovant Sciences Inc. | 6 | $95 |
| AstraZeneca | 4 | $77 |
| Amgen | 4 | $55 |
| EDAP Technomed Inc | 1 | $54 |
| Laborie Medical Technologies Corp. | 1 | $53 |
| Novartis | 3 | $50 |
| Antares Pharma, Inc. | 3 | $47 |
| Blue Earth Diagnostics | 2 | $47 |
| Urogen Pharma, Inc. | 2 | $40 |
| Tolmar Pharmaceuticals, Inc. | 2 | $33 |
| Endo Pharmaceuticals Inc. | 2 | $30 |
| Medtronic(2 entities) | 2 | $27 |
| Palette Life Sciences, Inc. | 1 | $22 |
| Endo USA, Inc. | 1 | $19 |
| Accord Healthcare, Inc. | 1 | $18 |
| Axonics, Inc. | 1 | $18 |
| Sanofi | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Telix Pharmaceuticals | 1 | $14 |
| Clarus Therapeutics Inc. | 1 | $13 |
How this compares
$196,394 in reported general payments places this provider in the 90th percentile of 199 urology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Lafayette
- William RothLafayette$41K
- Jeffrey ThibodeauxLafayette$8K
- Christopher FontenotLafayette$6K
- Jeremy SpeegLafayette$6K
- Ralph HendersonShreveport$4M
- Kevin ClineShreveport$1.3M
- Nathan FischmanNew Orleans$1.3M
- Ashley BakerShreveport$705K
- Colin GoudelockeNew Orleans$615K
- Stephen BardotNew Orleans$572K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.